• Home
  • Browse
    • Current Issue
    • By Issue
    • By Author
    • By Subject
    • Author Index
    • Keyword Index
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Editorial Staff
    • Publication Ethics
    • Indexing and Abstracting
    • Related Links
    • FAQ
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Reviewers
  • Contact Us
 
  • Login
  • Register
Home Articles List Article Information
  • Save Records
  • |
  • Printable Version
  • |
  • Recommend
  • |
  • How to cite Export to
    RIS EndNote BibTeX APA MLA Harvard Vancouver
  • |
  • Share Share
    CiteULike Mendeley Facebook Google LinkedIn Twitter
Sohag Medical Journal
arrow Articles in Press
arrow Current Issue
Journal Archive
Volume Volume 25 (2021)
Volume Volume 24 (2020)
Issue Issue 3
Issue Issue 2
Issue Issue 1
Volume Volume 23 (2019)
Volume Volume 22 (2018)
Volume Volume 21 (2017)
Abdel aziz, A., El said, H., Morsy, K., Galal, G. (2020). Hepatocellular carcinoma care during The Coronavirus disease (COVID-19) era. Sohag Medical Journal, 24(2), 76-81. doi: 10.21608/smj.2020.28553.1150
Ali Abdel aziz; Hammam Abo Elalamin El said; Khairy Hammam Morsy; Ghada Moustafa Galal. "Hepatocellular carcinoma care during The Coronavirus disease (COVID-19) era". Sohag Medical Journal, 24, 2, 2020, 76-81. doi: 10.21608/smj.2020.28553.1150
Abdel aziz, A., El said, H., Morsy, K., Galal, G. (2020). 'Hepatocellular carcinoma care during The Coronavirus disease (COVID-19) era', Sohag Medical Journal, 24(2), pp. 76-81. doi: 10.21608/smj.2020.28553.1150
Abdel aziz, A., El said, H., Morsy, K., Galal, G. Hepatocellular carcinoma care during The Coronavirus disease (COVID-19) era. Sohag Medical Journal, 2020; 24(2): 76-81. doi: 10.21608/smj.2020.28553.1150

Hepatocellular carcinoma care during The Coronavirus disease (COVID-19) era

Article 13, Volume 24, Issue 2, Spring 2020, Page 76-81  XML PDF (133.06 K)
DOI: 10.21608/smj.2020.28553.1150
Authors
Ali Abdel aziz email 1; Hammam Abo Elalamin El said2; Khairy Hammam Morsy3; Ghada Moustafa Galal3
1Tropical medicine and Gastroenterology department, Sohag Faculty of Medicine
2Department of Tropical Medicine and Gastroenterology, Faculty of Medicine, Sohag University
3Department of Tropical Medicine and Gastroenterology, Faculty of Medicine, Sohag University.
Abstract
The coronavirus pandemic (COVID-19) is now a great universal health problem and the biggest threat we have compete since World War Two. Since its emergence in china late last year, this virus has reached to all world continents except Antarctica. Cases in Europe, the Americas and Africa are growing regularly. COVID-19 pandemic is spreading like a wave-one that may yet crash on those least able to face. although COVID-19 is much more than just a health issue. All medical communities are facing a lot of challenges either in the prevention or in the treatment of this infection.COVID-19 is a hazardous infection especially in cancer patients that need a more immediate priority in obtaining medical care. Hepatocellular carcinoma (HCC) is the world's sixth most common malignant tumor and the fourth common malignant tumor in Egypt, also, Egypt is the third and fifteenth most crowded region in Africa and globally. This review aims to highlight the best measures that reduce the risk of deterioration in liver cancer patients leading to the best outcome in facing the COVID-19 pandemic.
Keywords
coronavirus (COVID-19)pandemic; Hepatocellular carcinoma(HCC); SARS-CoV(2)(sever acute respiratory syndrome corona virus type2)
Supplementary Files
download main article111.pdf
Statistics
Article View: 91
PDF Download: 96
Home | Glossary | News | Aims and Scope | Sitemap
Top Top

Journal Management System. Designed by NotionWave.